Erratum to: Muscosal effects for tenofovir 1% gel. eLife 4:e04525. doi: 10.7554/eLife.04525;Mucosal effects of tenofovir 1% gel

eLife

Volumn 2015, Issue 4, 2015, Pages 1-49

  Hladik, Florian ^a,b   Burgener, Adam ^d,e   Ballweber, Lamar ^b   Gottardo, Raphael ^a,b   Vojtech, Lucia ^a   Fourati, Slim ^c   Dai, James Y ^a,b   Cameron, Mark J ^c   Strobl, Johanna ^b   Hughes, Sean M ^a   Hoesley, Craig ^f   Andrew, Philip ^h   Johnson, Sherri ^h   Piper, Jeanna ⁱ   Friend, David R ^j   Ball, T Blake ^d,e   Cranston, Ross D ^g,l   Mayer, Kenneth H ^k   McElrath, M Juliana ^a,b   McGowan, Ian ^g,l  

^a UNIVERSITY OF WASHINGTON   (United States)

^b USA   (United States)

^c Departments of Vaccine and Gene Therapy Institute Florida   (United States)

^d UNIVERSITY OF MANITOBA   (Canada)

^e PUBLIC HEALTH AGENCY OF CANADA   (Canada)

^f UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^g UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^h FAMILY HEALTH INTERNATIONAL   (United States)

ⁱ NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^j EASTERN VIRGINIA MEDICAL SCHOOL   (United States)

^k HARVARD MEDICAL SCHOOL   (United States)

^l UNIVERSITY OF PITTSBURGH   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 10; NONOXINOL 9; NORMOSOL; TENOFOVIR; GEL; RNA DIRECTED DNA POLYMERASE INHIBITOR;

ADULT; AGED; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BIOMICS; BIOPSY; CELL DENSITY; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SURVIVAL; CELL VIABILITY ASSAY; CLINICAL ARTICLE; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MASS SPECTROMETRY; MICROARRAY ANALYSIS; MITOCHONDRIAL DNA DISORDER; MUCOSA; RANDOMIZED CONTROLLED TRIAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VERY ELDERLY; CLINICAL TRIAL; DRUG EFFECTS; GEL; METABOLISM; MITOCHONDRION; PHASE 1 CLINICAL TRIAL; PROTEOMICS; RECTUM; VAGINA;

DOUBLE-BLIND METHOD; FEMALE; GELS; GENE EXPRESSION; HUMANS; MALE; MITOCHONDRIA; MUCOUS MEMBRANE; PROTEOMICS; RECTUM; REVERSE TRANSCRIPTASE INHIBITORS; TENOFOVIR; VAGINA;

EID: 84964698405     PISSN: None     EISSN: 2050084X     Source Type: Journal    
DOI: 10.7554/eLife.07586     Document Type: Erratum

References (54)

1. Abdool Karim Q, Abdool Karim SS, Frohlich JA, Grobler AC, Baxter C, et al. (2010) Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women. Science 329: 1168-1174.
2. Marrazzo J, Ramjee G, Nair G, Palanee T, Mkhize B, et al. (2013) Pre-exposure prophylaxis for HIV in women: daily oral tenofovir, oral tenofovir/emtricitabine, or vaginal tenofovir gel in the VOICE study (MTN 003). 20th Conference on Retroviruses and Opportunistic Infections. Atlanta. pp. 26LB.
3. McGowan I, Hoesley C, Cranston RD, Andrew P, Janocko L, et al. (2013) A phase 1 randomized, double blind, placebo controlled rectal safety and acceptability study of tenofovir 1% gel (MTN-007). PLoS ONE 8: e60147.
4. Tien D, Schnaare RL, Kang F, Cohl G, McCormick TJ, et al. (2005) In vitro and in vivo characterization of a potential universal placebo designed for use in vaginal microbicide clinical trials. AIDS Res Hum Retroviruses 21: 845-853.
5. Chapman S, Liu X, Meyers C, Schlegel R, McBride AA (2010) Human keratinocytes are efficiently immortalized by a Rho kinase inhibitor. J Clin Invest 120: 2619-2626.
6. Liu X, Ory V, Chapman S, Yuan H, Albanese C, et al. (2012) ROCK inhibitor and feeder cells induce the conditional reprogramming of epithelial cells. Am J Pathol 180: 599-607.
7. Rheinwald JG, Green H (1975) Serial cultivation of strains of human epidermal keratinocytes: the formation of keratinizing colonies from single cells. Cell 6: 331-343.
8. Hendrix CW, Chen BA, Guddera V, Hoesley C, Justman J, et al. (2013) MTN-001: randomized pharmacokinetic cross-over study comparing tenofovir vaginal gel and oral tablets in vaginal tissue and other compartments. PLoS ONE 8: e55013.
9. Louissaint NA, Cao YJ, Skipper PL, Liberman RG, Tannenbaum SR, et al. (2013) Single Dose Pharmacokinetics of Oral Tenofovir in Plasma, Peripheral Blood Mononuclear Cells, Colonic and Vaginal Tissue. AIDS Res Hum Retroviruses.
10. Anton PA, Saunders T, Elliott J, Khanukhova E, Dennis R, et al. (2011) First phase 1 double-blind, placebo-controlled, randomized rectal microbicide trial using UC781 gel with a novel index of ex vivo efficacy. PLoS ONE 6: e23243.
11. Burgener A, Tjernlund A, Kaldensjo T, Abou M, McCorrister S, et al. (2013) A systems biology examination of the human female genital tract shows compartmentalization of immune factor expression. J Virol 87: 5141-5150.
12. Gentleman RC, Carey VJ, Bates DM, Bolstad B, Dettling M, et al. (2004) Bioconductor: open software development for computational biology and bioinformatics. Genome Biol 5: R80.
13. Du P, Kibbe WA, Lin SM (2008) lumi: a pipeline for processing Illumina microarray. Bioinformatics 24: 1547-1548.
14. Lin SM, Du P, Huber W, Kibbe WA (2008) Model-based variance-stabilizing transformation for Illumina microarray data. Nucleic Acids Res 36: e11.
15. Bourgon R, Gentleman R, Huber W (2010) Independent filtering increases detection power for high-throughput experiments. Proc Natl Acad Sci U S A 107: 9546-9551.
16. Baldi P, Long AD (2001) A Bayesian framework for the analysis of microarray expression data: regularized t -test and statistical inferences of gene changes. Bioinformatics 17: 509­519.
17. Long AD, Mangalam HJ, Chan BY, Tolleri L, Hatfield GW, et al. (2001) Improved statistical inference from DNA microarray data using analysis of variance and a Bayesian statistical framework. Analysis of global gene expression in Escherichia coli K12. J Biol Chem 276: 19937-19944.
18. Benjamin Y, Hochberg Y (1995) Controlling the false discovery rate: A practical and powerful approach to multiple testing. Journal of the Royal Statistical Society, Series B (Methodological) 57: 289-300.
19. Smyth GK (2005) Limma: linear models for microarray data. In: Gentleman R, Carey V, Dudoit S, Irizarry R, Huber W, editors. Bioinformatics and Computational Biology Solutions using R and Bioconductor. New York: Springer. pp. 397-420.
20. Saeed AI, Bhagabati NK, Braisted JC, Liang W, Sharov V, et al. (2006) TM4 microarray software suite. Methods Enzymol 411: 134-193.
21. Huang da W, Sherman BT, Lempicki RA (2009) Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 4: 44-57.
22. Lynn DJ, Winsor GL, Chan C, Richard N, Laird MR, et al. (2008) InnateDB: facilitating systems-level analyses of the mammalian innate immune response. Mol Syst Biol 4: 218.
23. Hindson BJ, Ness KD, Masquelier DA, Belgrader P, Heredia NJ, et al. (2011) High- throughput droplet digital PCR system for absolute quantitation of DNA copy number. Anal Chem 83: 8604-8610.
24. Pinheiro LB, Coleman VA, Hindson CM, Herrmann J, Hindson BJ, et al. (2012) Evaluation of a droplet digital polymerase chain reaction format for DNA copy number quantification. Anal Chem 84: 1003-1011.
25. Hladik F, Sakchalathorn P, Ballweber L, Lentz G, Fialkow M, et al. (2007) Initial events in establishing vaginal entry and infection by human immunodeficiency virus type-1. Immunity 26: 257-270.
26. Hladik F, Lentz G, Akridge RE, Peterson G, Kelley H, et al. (1999) Dendritic cell-T-cell interactions support coreceptor-independent human immunodeficiency virus type 1 transmission in the human genital tract. J Virol 73: 5833-5842.
27. Collins TJ (2007) ImageJ for microscopy. Biotechniques 43: 25-30.
28. Alvarez Y, Municio C, Alonso S, Sanchez Crespo M, Fernandez N (2009) The induction of IL-10 by zymosan in dendritic cells depends on CREB activation by the coactivators CREB- binding protein and TORC2 and autocrine PGE2. J Immunol 183: 1471-1479.
29. Woodgett JR, Ohashi PS (2005) GSK3: an in-Toll-erant protein kinase? Nat Immunol 6: 751-752.
30. Neuhofer W (2011) Role of NFAT5 in inflammatory disorders associated with osmotic stress. Curr Genomics 11: 584-590.
31. Wang G, Chen HW, Oktay Y, Zhang J, Allen EL, et al. (2010) PNPASE regulates RNA import into mitochondria. Cell 142: 456-467.
32. Misaka T, Miyashita T, Kubo Y (2002) Primary structure of a dynamin-related mouse mitochondrial GTPase and its distribution in brain, subcellular localization, and effect on mitochondrial morphology. J Biol Chem 277: 15834-15842.
33. Yu P, Huang B, Shen M, Lau C, Chan E, et al. (2001) p15(PAF), a novel PCNA associated factor with increased expression in tumor tissues. Oncogene 20: 484-489.
34. Dumond JB, Nicol MR, Kendrick RN, Garonzik SM, Patterson KB, et al. (2012) Pharmacokinetic modelling of efavirenz, atazanavir, lamivudine and tenofovir in the female genital tract of HIV-infected pre-menopausal women. Clin Pharmacokinet 51: 809-822.
35. Lee CG, Ren J, Cheong IS, Ban KH, Ooi LL, et al. (2003) Expression of the FAT10 gene is highly upregulated in hepatocellular carcinoma and other gastrointestinal and gynecological cancers. Oncogene 22: 2592-2603.
36. Houstek J, Pickova A, Vojtiskova A, Mracek T, Pecina P, et al. (2006) Mitochondrial diseases and genetic defects of ATP synthase. Biochim Biophys Acta 1757: 1400-1405.
37. Lewis W, Day BJ, Copeland WC (2003) Mitochondrial toxicity of NRTI antiviral drugs: an integrated cellular perspective. Nat Rev Drug Discov 2: 812-822.
38. Anton PA, Cranston RD, Kashuba A, Hendrix CW, Bumpus NN, et al. (2012) RMP- 02/MTN-006: A Phase 1 Rectal Safety, Acceptability, Pharmacokinetic, and Pharmacodynamic Study of Tenofovir 1% Gel Compared with Oral Tenofovir Disoproxil Fumarate. AIDS Res Hum Retroviruses 28: 1412-1421.
39. Martin M, Rehani K, Jope RS, Michalek SM (2005) Toll-like receptor-mediated cytokine production is differentially regulated by glycogen synthase kinase 3. Nat Immunol 6: 777­784.
40. Gee K, Angel JB, Ma W, Mishra S, Gajanayaka N, et al. (2006) Intracellular HIV-Tat expression induces IL-10 synthesis by the CREB-1 transcription factor through Ser133 phosphorylation and its regulation by the ERK1/2 MAPK in human monocytic cells. J Biol Chem 281: 31647-31658.
41. Konkel JE, Chen W (2011) Balancing acts: the role of TGF-beta in the mucosal immune system. Trends Mol Med 17: 668-676.
42. Surh CD, Sprent J (2012) TGF-beta puts the brakes on homeostatic proliferation. Nat Immunol 13: 628-630.
43. Ansel KM, Harris RB, Cyster JG (2002) CXCL13 is required for B1 cell homing, natural antibody production, and body cavity immunity. Immunity 16: 67-76.
44. Forster R, Davalos-Misslitz AC, Rot A (2008) CCR7 and its ligands: balancing immunity and tolerance. Nat Rev Immunol 8: 362-371.
45. Naranbhai V, Abdool Karim SS, Altfeld M, Samsunder N, Durgiah R, et al. (2012) Innate Immune Activation Enhances HIV Acquisition in Women, Diminishing the Effectiveness of Tenofovir Microbicide Gel. J Infect Dis.
46. Perazella MA (2010) Tenofovir-induced kidney disease: an acquired renal tubular mitochondriopathy. Kidney Int 78: 1060-1063.
47. Modica-Napolitano JS, Kulawiec M, Singh KK (2007) Mitochondria and human cancer. Curr Mol Med 7: 121-131.
48. Ni Chonghaile T, Sarosiek KA, Vo TT, Ryan JA, Tammareddi A, et al. (2011) Pretreatment mitochondrial priming correlates with clinical response to cytotoxic chemotherapy. Science 334: 1129-1133.
49. Shidara Y, Yamagata K, Kanamori T, Nakano K, Kwong JQ, et al. (2005) Positive contribution of pathogenic mutations in the mitochondrial genome to the promotion of cancer by prevention from apoptosis. Cancer Res 65: 1655-1663.
50. Kashuba AD, Patterson KB, Dumond JB, Cohen MS (2012) Pre-exposure prophylaxis for HIV prevention: how to predict success. Lancet 379: 2409-2411.
51. Jain M, Zhang L, Patterson EE, Kebebew E (2011) KIAA0101 is overexpressed, and promotes growth and invasion in adrenal cancer. PLoS ONE 6: e26866.
52. Ren J, Kan A, Leong SH, Ooi LL, Jeang KT, et al. (2006) FAT10 plays a role in the regulation of chromosomal stability. J Biol Chem 281: 11413-11421.
53. Ren J, Wang Y, Gao Y, Mehta SB, Lee CG (2011) FAT10 mediates the effect of TNF-alpha in inducing chromosomal instability. J Cell Sci 124: 3665-3675.
54. Ayers KM, Clive D, Tucker WE, Jr., Hajian G, de Miranda P (1996) Nonclinical toxicology studies with zidovudine: genetic toxicity tests and carcinogenicity bioassays in mice and rats. Fund Appl Toxicol 32: 148-158.